| DB15897 | Etesevimab | investigational | yes | binder | Details |
| DB15718 | Bamlanivimab | approved, investigational | yes | antagonist | Details |
| DB15691 | Anti-SARS-CoV-2 REGN-COV2 | investigational | yes | binder | Details |
| DB15940 | Imdevimab | approved, experimental | yes | binder | Details |
| DB15941 | Casirivimab | approved, experimental | yes | binder | Details |
| DB16355 | Sotrovimab | approved, investigational | unknown | binder | Details |
| DB16405 | Regdanvimab | approved, investigational | yes | antibody | Details |
| DB16393 | Cilgavimab | approved, investigational | yes | binder | Details |
| DB16394 | Tixagevimab | approved, investigational | yes | binder | Details |
| DB16755 | Bebtelovimab | investigational, withdrawn | yes | antibody | Details |
| DB12411 | Bemcentinib | investigational | yes | inhibitor | Details |